Literature DB >> 9338135

Osteopontin overexpression in vascular smooth muscle cells transfected with the c-Ha-rasEJ oncogene.

A R Parrish, T J Weber, K S Ramos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9338135     DOI： 10.1007/s11626-997-0103-5

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  16 in total

1.  Novel ATP-binding heat-inducible protein of Mr = 37,000 that is sensitive to transformation in BALB/3T3 cells.

Authors:  A Nakai; C Hirayama; K Ohtsuka; K Hirayoshi; K Nagata
Journal:  J Cell Physiol       Date:  1990-06       Impact factor: 6.384

2.  c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype.

Authors:  D N Sadhu; M S Lundberg; R C Burghardt; K S Ramos
Journal:  J Cell Physiol       Date:  1994-12       Impact factor: 6.384

3.  Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation.

Authors:  H Matsuno; J M Stassen; J Vermylen; H Deckmyn
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

4.  Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts.

Authors:  A Wolfman; I G Macara
Journal:  Nature       Date:  1987 Jan 22-28       Impact factor: 49.962

5.  Growth in serum-free medium of NIH3T3 cells transformed by the EJ-H-ras oncogene: evidence for multiple autocrine growth factors.

Authors:  M Pironin; G Clément; O Benzakour; D Barritault; D Lawrence; P Vigier
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

6.  The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.

Authors:  A J Oates; R Barraclough; P S Rudland
Journal:  Oncogene       Date:  1996-07-04       Impact factor: 9.867

7.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.

Authors:  C M Giachelli; N Bae; M Almeida; D T Denhardt; C E Alpers; S M Schwartz
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.

Authors:  D W Stacey; H F Kung
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

Review 9.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

10.  Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell.

Authors:  X Guo; Y P Zhang; D A Mitchell; D T Denhardt; A F Chambers
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.